WHO advises against prescribing remdesivir to Covid patients
Gilead drug has no effect on survival or need for ventilation, says health body
Full Article
WHO advises against prescribing remdesivir to Covid patients
FT.com
0 shares
1 views
You might like
Related news coverage
Dilemma for State over Remdesivir
Hindu
WHO sceptical about efficacy of costly drug used to treat serious COVID patients
-
Humanigen showing positive results for cancer drug lenzilumab, also used to treat patients hospitalized with coronavirus
Proactive Investors
-
California begins curfew to curb COVID-19
VOA News
-
'Not of use for much': Hospitals told not to give remdesivir to COVID-19 patients
Upworthy
-
Post Holdings, Gilead Sciences fall; Pfizer, Hibbett rise
SeattlePI.com
Advertisement
More coverage
WHO pours cold water on Gilead's Covid drug remdesivir
bizjournals
The only drug with full Food and Drug Administration approval to treat Covid-19 patients is getting dissed by the World Health..
-
Don't use Gilead's Remdesivir in hospitalised COVID-19 patients: WHO
Zee News
-
WHO Trial Finds Remdesivir Has 'No Meaningful Effect' In COVID-19 Patients
NPR
-
WHO Advises Against Use of Remdesivir on COVID Patients
VOA News
-
WHO advises against use of remdesivir for hospitalised COVID-19 patients
newKerala.com